Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Making remissions last: the promise of maintenance in primary central nervous system lymphoma.
Journal: Haematologica
Published: July 23, 2026
IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.
Journal: Future oncology (London, England)
Published: June 19, 2026
Redefining consolidation in primary CNS lymphoma: autologous stem-cell transplantation as the standard.
Journal: Lancet (London, England)
Published: April 28, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem Gliomas.
Journal: JCO precision oncology
Published: February 25, 2026
Representation of neuro-oncology in American neurology departments: An analysis of Grand Rounds and perspectives from faculty and residents.
Journal: Neuro-oncology practice
Published: December 29, 2025
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine for newly diagnosed primary CNS lymphoma.
Journal: Neuro-oncology
Published: December 18, 2025
Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.
Journal: Neuro-oncology
Published: August 22, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma.
Journal: Neuro-oncology
Published: August 04, 2025
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.
Journal: Neuro-oncology practice
Published: July 10, 2025
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.
Journal: Acta neuropathologica
Published: June 20, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide, and rituximab in patients with relapsed/refractory central nervous system lymphoma.
Journal: Neuro-oncology
Published: April 24, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
Journal: British journal of haematology
Published: March 20, 2025
Last Updated: 09/26/2026